                Figure 2.  Primary efficacy outcome: mean time to PC90 (±95% confidence intervals) in the Day 3 per-protocol population for (a) adults and (b) children.*P ≤0.05 versus CPG−DDS alone; **P ≤0.01 versus CPG–DDS alone.

